compared to those with less GCs. 6 Moreover, physiological changes profoundly affect granulosa cell number and oocyte quality; for example, oocytes of age cows, compared to that of younger counterparts, have low developmental competence and lower number of surrounding GCs. 7 From these studies, it seems conceivable that manipulation of granulosa cell number could improve oocyte development.
It has been reported that GCs and denuded oocytes derived from the porcine early antral follicle (EAF) can reconstruct a new oocyte-granulosa cell complex (OGC), and this structure helps the oocyte to acquire the developmental ability to the blastocyst stage. 8 In addition, the addition of GCs derived from EAFs to OGCs supports the growth of bovine oocytes derived from EAFs. 9 However, the collection of GCs from EAFs is laborious work, while collection from antral follicles (AFs) is easy. Moreover, characteristics of the GCs change during follicle development, 10 yet whether GCs from more advanced stage follicles supports the development of oocytes derived from EAFs is unclear.
In the present study, we collected OGCs from EAFs of porcine ovaries, and cultured the OGCs with or without additional granulosa cells masses, which were collected from EAFs or AFs, and examined the properties and parthenogenetic developmental abilities of the oocytes grown in vitro.
| MATERIAL S AND ME THODS

| Media and chemicals
All reagents were purchased from Nacalai Tesque (Kyoto, Japan), unless otherwise stated. For the collection of OGCs from EAFs, we used minimum essential medium (MEM; Sigma-Aldrich, St. Louis, MO, USA) supplemented with 5 mmol/L taurine, 5 mmol/L mannitol, 0.68 mmol/L l-glutamine, 1 mg/mL BSA (Fraction V), and antibiotics.
For culture of OGCs, we used α-MEM (Sigma-Aldrich) supplemented with 10 mmol/L taurine, 0.1 mAU/mL follicle-stimulating hormone (Kawasaki Mitaka, Tokyo, Japan), 2% polyvinylpyrrolidone-360 (Sigma-Aldrich), 2 mmol/L hypoxanthine (Sigma-Aldrich), 1% insulin transferrin selenium (Gibco BRL, Paisley, UK), 1 µg/mL 17β-estradiol, 3 mg/mL BSA, and antibiotics. The in vitro maturation medium consisted of Medium 199 (Gibco) 11 supplemented with 10% porcine follicular fluid (pFF), 0.5 mmol/L l-cysteine, 0.9 mmol/L sodium pyruvate, 1 mmol/L l-glutamine, 10 ng/mL epidermal growth factor, 5% fetal calf serum, 10 IU/mL equine chorionic gonadotropin (ASKA Pharma Co. Ltd, Tokyo, Japan), and 10 IU/mL human chorionic gonadotropin (Fuji Pharma Co. Ltd, Tokyo, Japan). The pFF supplemented to the maturation medium was aspirated from AFs (3-5 mm in diameter) and centrifuged for 20 minutes. The resulting supernatants were collected, sterilized, and stored at −20°C until use. In vitro culture of embryos and oocyte activation was conducted in porcine zygote medium 3 (PZM3). 12 In vitro culture of OGCs and oocyte maturation was performed at 38.5°C in an atmosphere containing 5% CO 2 and 95% air, whereas in vitro embryo culture was performed at 38.5°C in an atmosphere containing 5% O 2 , 5% CO 2 , and 90% N 2 .
| Collection of ovaries and OGCs
Ovaries were collected from prepubertal gilts at a local slaughter- 
| Collection of granulosa cells (GCs) and their addition to OGCs
Granulosa cells were collected from EAFs and AFs of gilts ovaries.
GCs of EAFs were retrieved from randomly selected OGCs using narrow-pulled glass pipettes. GCs of AFs were collected from large F I G U R E 1 Diameter of oocytes grown in vitro. Granulosa cells (Gcs) masses were collected from early antral follicles (EAFs) and the volume of the GC masses was processed to 1/3, 1/2, and 1/1 levels of the oocyte-GCs (OGCs). GCs and OGCs were cocultured for 14 d. Diameters of 24 oocytes grown in vitro were measured. a-b, P < 0.05 antral follicles (3-5 mm in diameter); antral follicles were carefully ruptured in a share and granulosa cell masses were collected under stereomicroscope. The volume of the GCs was processed depending on experimental design under stereomicroscope. Figure 1 shows representative pictures of OGC cultures where GCs were added to the OGCs. From here on in, we use the term "natural OGCs" to represent OGCs collected from EAFs but were otherwise unmanipulated. In addition, we use "EAF-GCs add OGCs" and "AF-OGCs add
OGCs" for OGCs that were formed from the addition of GCs derived from EAFs and AFs, respectively.
| Measurement of oocyte diameter and number of GCs
The diameter of the ooplasm was measured under a digital microscope (Keyence). To determine the number of GCs in OGCs, the GCs were dispersed by vigorous pipetting in Accumax (Innovative Cell Technology, San Diego, CA, USA), and total cell number was calculated using a hemo-cytometer to obtain an average granulosa cell number per OGC.
| Measurement of lipid content in oocytes
After in vitro growth culture, oocytes were denuded from GCs using a narrow-pulled glass pipette, fixed in 4% paraformaldehyde, and 
| IVM, activation, and in vitro culture (IVC)
After in vitro growth (14 days), OGCs with an antrum cavity were used for further experiment or subsequent in vitro maturation (48 hours).
Then, oocyte activation was conducted, whereby oocytes were denuded from GCs in the in vitro culture (IVC) medium droplets and treated with 10 µmol/L ionomycin for 5 minutes followed by culture in in vitro culture (IVC) medium containing 10 µmol/L Cytochalasin B and 10 µmol/L cycloheximide for 5 hours. After activation, the embryos were cultured for 8 days in IVC medium, and the rate of blastulation and the total blastocyst cell numbers were determined after staining blastocysts with DAPI and by fluorescence microscopy analysis.
| Pimonidazole staining
The OGCs (Days 2 of culture period) were immunostained against pi- 
| Data analysis
Among the three culture conditions, comparisons of the rate of antrum formation, granulosa cell number, survival rate of the cells, diameter of oocytes, and lipid content in cells were performed using analysis of variance followed by Tukey's post hoc test. The data related to developmental rate were compared using Chi-square test.
The rates were arcsine-transformed prior to analysis. A P value <0.05 was considered to denote statistical significance.
| RE SULTS
| OGCs cocultured with granulosa cells from EAFs
The volume of granulosa cells mass to be added to the OGCs was examined by measuring the diameter of the oocyte grown in vitro, because the diameter of the oocyte is a fundamental marker of oocyte growth.
Granulosa cells were collected from EAFs and the volume of the
GCs was processed into one-third (1/3GC), one-half (1/2GC), or all GCs (1/1GC), were added to the OGCs. After 16 days, oocyte diameters of 24 oocytes from each group were examined. We found that the addition of 1/2 and 1/1GC to OGCs reduced the diameter of oocytes grown in vitro in a volume-dependent manner, and there were no differences between natural and 1/3GCs (Figure 1 ). Therefore, we used 1/3GC in subsequent experiments.
| GC derived from AFs contributes to oocyte growth
When 1/3GC derived from either EAFs or AFs were added to the OGCs, the GCs and OGCs reaggregated to form "reconstructed OGCs" till day 2 of culture. To visualize the contribution of the additional GCs, GCs derived from EAFs and AFs were pre-stained with cell trackers (AAT Bioquest, Sunnyvale, CA, USA) and added to the OGCs. Two days after in vitro culture, OGCs were observed under a fluorescence microscope (Figure 2 ). These OGCs were morphologically similar to natural OGCs, and GCs derived from EAFs and AFs similarly contributed to the structure of new OGCs.
| Addition of GCs derived from AFs improves oocyte growth in vitro
The effect of GC addition on oocyte growth was evaluated. In the present experiment, 10 OGCs were cultured in vitro and the culture was repeated 23 times. During in vitro culture, the rate of antrum formation was comparable between "AF-GCs add OGCs" and "natural OGCs", but these rates were significantly higher than that of "EAF-GCs add OGCs" (Figure 3 ). For the first four of 23 trials, the number and survival rate of the GCs in the OGCs were examined.
The number of GCs was comparable among the three OGC groups, whereas survival rate of the GCs was the highest for "AF-GCs add
OGCs" (Table 1 ). In addition, the diameter of the oocytes grown in "AF-GCs add OGCs" was significantly greater than that of oocytes developed in "EAFs-GCs add OGCs" and "natural OGCs" ( Table 1) .
As lipid content in oocytes is a biomarker of oocyte ability, 13, 14 we examined the lipid content in the oocytes, and we found significantly higher lipid content in oocytes grown in both "EAF-GCs add OGCs"
and "AF-GCs add OGCs" compared with the natural counterparts ( Figure 4 ).
In the next six trials, the oocytes developed in the three
OGCs conditions were subjected to assay for in vitro maturation.
Maturation rate were comparative (P > 0.71) among the experimental groups (AF-GCs add OGCs, 51.9 ± 3.2, EAF-GCs add OGCs, 53.2 ± 5.8 and natural OGCs, 58.0 ± 11.2). In the next 13 trials, the oocytes developed in the three OGCs conditions were subjected to parthenogenetic activation to determine their developmental ability to the blastocyst stage. The rate of blastulation was 7.0%, 5.6%, and 3.5% for "AF-GCs add OGCs," "EAF-GCs add OGCs," and "natural OGCs," respectively, while there was no significant difference among them (Table 2 ).
| Addition of GC induces hypoxia in the OGCs
Hypoxia-induced increase in VEGFA and HIF1 occurs upstream of glycolysis activation in GCs, 15 and we previously found a metabolic shift in the GCs to glycolysis and activation of HIF1a and VEGFA in the GCs along with follicle development. 10 We therefore examined whether the addition of GCs induced hypoxic conditions in the OGCs, using pimonidazole staining, which reflects the hypoxic conditions of cell. We found that the addition of AF-GCs to OGCs significantly induced hypoxia in OGCs ( Figure 5 ).
| D ISCUSS I ON
The present study shows that the addition of GCs collected from more advanced follicle stages to OGCs culture conditions supports oocyte growth. We performed in vitro oocyte growth in 200 μL of culture medium in 96-well plates, and as it is generally accepted that an optimal concentration of cells should be present for each culture conditions. Based on the diameter of oocytes, we concluded that GC volumes greater than a certain threshold (1/3) adversely affected oocyte growth. Considering these results, we added one-third volume of GCs to OGCs. When coculturing the GCs and OGCs, GCs were incorporated into the OGCs within 2 days and new OGCs were HIF1A and genes associated with glycolysis, 10 which is a prominent difference between the two follicular stages. Glycolytic activity and HIF1A expression in GCs were reported to be enhanced by hypoxic conditions. 15 Consistent with this notion, in this study, we found that the addition of AF-GCs to the OGCs induced a more hypoxic condition for the OGCs ( Figure 5 ). In line with this, Hirao et al showed that low oxygen tension at the first 4 days of culture period enhanced in vitro bovine oocyte growth. 16 From these results, we suggested that the addition of GCs to OGCs at the start of in vitro culture provided a more hypoxic environment to the OGCs compared with those natural OGCs, and the priming effect of GC addition was greater for more advanced stage follicles. Another major impact of GCs addition to oocyte was the high lipid content in the oocytes. Lipid content is a simple but important oocyte marker associated with high developmental abilities. 13, 14 Many factors have been reported to affect lipid content in oocytes; for example, higher lipid content in culture medium increased lipid content in oocyte and GCs. 17 In addition, TA B L E 1 Effect of granulosa cells (GCs) addition to the oocyte-granulosa cell complexes (OGCs) on number and survival rate of the GCs and diameter of the oocytes grown in vitro a greater number of GCs increased lipid content of oocytes grown in vitro, 4, 18 suggesting that high energy conditions are associated with lipid accumulation in oocytes. In the present study, we did not find any difference in GC numbers between GC-added OGCs and natural OGCs. We, therefore, speculated that GCs derived from more advanced stage follicles induce more metabolic changes in oocytes and/or GCs resulting in oocyte growth and lipid accumulation; however, this point should be further studied in the future.
In conclusion, GCs derived from AFs contribute to the development of OGCs derived from EAFs and improve oocyte growth in vitro. 
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